Interventions for lowering plasma homocysteine levels in kidney transplant recipients.

CONCLUSIONS: There is no current evidence to support the use of homocysteine lowering therapy for cardiovascular disease prevention in kidney transplant recipients. PMID: 25938479 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25938479?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - May 4, 2015 Category: Journals (General) Authors: Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine MJ Tags: Cochrane Database Syst Rev Source Type: research